Precigen (PGEN) Return on Equity (2013 - 2026)

Precigen (PGEN) has 14 years of Return on Equity data on file, last reported at 0.1% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.1%, up 3.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1% (up 3.0% YoY), and the FY2025 annual result was 0.08%, changed N/A from the prior year.
• Return on Equity fell to 0.1% in Q1 2026 per PGEN's latest filing, from 0.08% in the prior quarter.
• Over five years, Return on Equity peaked at 0.05% in Q2 2025 and troughed at 0.97% in Q3 2025.
• A 5-year average of 0.08% and a median of 0.0% in 2024 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 6 bps in 2025 and fell as far as 95 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then sank by 33 bps to 0.01% in 2023, then slumped by 596 bps to 0.03% in 2024, then slumped by 197 bps to 0.08% in 2025, then retreated by 24 bps to 0.1% in 2026.
• Business Quant data shows PGEN's Return on Equity at 0.1% in Q1 2026, 0.08% in Q4 2025, and 0.97% in Q3 2025.